|
1
|
Sedlarikova L, Kubiczkova L, Sevcikova S
and Hajek R: Mechanism of immunomodulatory drugs in multiple
myeloma. Leuk Res. 36:1218–1224. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Harousseau JL: Thalidomide in multiple
myeloma: past, present and future. Future Oncol. 2:577–589. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Björkstrand B and Gahrton G: High-dose
treatment with autologous stem cell transplantation in multiple
myeloma: past, present, and future. Semin Hematol. 44:227–233.
2007.PubMed/NCBI
|
|
4
|
Zeng R, Chen Y, Zhao S and Cui GH:
Autophagy counteracts apoptosis in human multiple myeloma cells
exposed to oridonin in vitro via regulating intracellular ROS and
SIRT1. Acta Pharmacol Sin. 33:91–100. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Maquart FX, Chastang F, Simeon A,
Birembaut P, Gillery P and Wegrowski Y: Triterpenes from
Centella asiatica stimulate extracellular matrix
accumulation in rat experimental wounds. Eur J Dermatol. 9:289–296.
1999.
|
|
6
|
Soo Lee Y, Jin DQ, Beak SM, Lee ES and Kim
JA: Inhibition of ultraviolet-A-modulated signaling pathways by
asiatic acid and ursolic acid in HaCaT human keratinocytes. Eur J
Pharmacol. 476:173–178. 2003.PubMed/NCBI
|
|
7
|
Xu MF, Xiong YY, Liu JK, Qian JJ, Zhu L
and Gao J: Asiatic acid, a pentacyclic triterpene in Centella
asiatica, attenuates glutamate-induced cognitive deficits in
mice and apoptosis in SH-SY5Y cells. Acta Pharmacol Sin.
33:578–587. 2012.PubMed/NCBI
|
|
8
|
Patil SP, Maki S, Khedkar SA, Rigby AC and
Chan C: Withanolide A and asiatic acid modulate multiple targets
associated with amyloid-beta precursor protein processing and
amyloid-beta protein clearance. J Nat Prod. 73:1196–1202. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tang LX, He RH, Yang G, et al: Asiatic
acid inhibits liver fibrosis by blocking TGF-beta/Smad signaling in
vivo and in vitro. PLoS One. 7:e313502012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Park BC, Paek SH, Lee YS, et al:
Inhibitory effects of asiatic acid on
7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol
13-acetate-induced tumor promotion in mice. Biol Pharm Bull.
30:176–179. 2007.PubMed/NCBI
|
|
11
|
Lee YS, Jin DQ, Kwon EJ, et al: Asiatic
acid, a triterpene, induces apoptosis through intracellular
Ca2+ release and enhanced expression of p53 in HepG2
human hepatoma cells. Cancer Lett. 186:83–91. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hsu YL, Kuo PL, Lin LT and Lin CC: Asiatic
acid, a triterpene, induces apoptosis and cell cycle arrest through
activation of extracellular signal-regulated kinase and p38
mitogen-activated protein kinase pathways in human breast cancer
cells. J Pharmacol Exp Ther. 313:333–344. 2005. View Article : Google Scholar
|
|
13
|
Park BC, Bosire KO, Lee ES, Lee YS and Kim
JA: Asiatic acid induces apoptosis in SK-MEL-2 human melanoma
cells. Cancer Lett. 218:81–90. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cho CW, Choi DS, Cardone MH, Kim CW,
Sinskey AJ and Rha C: Glioblastoma cell death induced by asiatic
acid. Cell Biol Toxicol. 22:393–408. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tang XL, Yang XY, Jung HJ, et al: Asiatic
acid induces colon cancer cell growth inhibition and apoptosis
through mitochondrial death cascade. Biol Pharm Bull. 32:1399–1405.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu H, Liu XW, Cai TY, et al: Celastrol
acts as a potent antimetastatic agent targeting beta1 integrin and
inhibiting cell-extracellular matrix adhesion, in part via the p38
mitogen-activated protein kinase pathway. J Pharmacol Exp Ther.
334:489–499. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang SY, Hao HL, Deng K, et al: Expression
levels of phosphatase and tensin homolog deleted on chromosome 10
(PTEN) and focal adhesion kinase in patients with multiple myeloma
and their relationship to clinical stage and extramedullary
infiltration. Leuk Lymphoma. 53:1162–1168. 2012. View Article : Google Scholar
|
|
18
|
Schmidmaier R, Mandl-Weber S, Gaul L, et
al: Inhibition of lymphocyte function associated antigen 1 by
LFA878 induces apoptosis in multiple myeloma cells and is
associated with downregulation of the focal adhesion
kinase/phosphatidylinositol 3 kinase/Akt pathway. Int J Oncol.
31:969–976. 2007.
|
|
19
|
Ko BS, Chang TC and Liou JY: Focal
adhesion kinase as a therapeutic target of bortezomib. Anticancer
Agents Med Chem. 10:747–752. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ko BS, Chang TC, Chen CH, et al:
Bortezomib suppresses focal adhesion kinase expression via
interrupting nuclear factor-kappa B. Life Sci. 86:199–206. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hofmann T, Klenow S, Borowicki A, Gill CI,
Pool-Zobel BL and Glei M: Gene expression profiles in human
peripheral blood mononuclear cells as biomarkers for nutritional in
vitro and in vivo investigations. Genes Nutr. 5:309–319. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Smith M and Boon HS: Counseling cancer
patients about herbal medicine. Patient Educ Couns. 38:109–120.
1999. View Article : Google Scholar
|
|
23
|
Gurfinkel DM, Chow S, Hurren R, et al:
Disruption of the endoplasmic reticulum and increases in
cytoplasmic calcium are early events in cell death induced by the
natural triterpenoid Asiatic acid. Apoptosis. 11:1463–1471. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
McLean GW, Carragher NO, Avizienyte E,
Evans J, Brunton VG and Frame MC: The role of focal-adhesion kinase
in cancer - a new therapeutic opportunity. Nat Rev Cancer.
5:505–515. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Michael KE, Dumbauld DW, Burns KL, Hanks
SK and García AJ: Focal adhesion kinase modulates cell adhesion
strengthening via integrin activation. Mol Biol Cell. 20:2508–2519.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Parsons JT, Martin KH, Slack JK, Taylor JM
and Weed SA: Focal adhesion kinase: a regulator of focal adhesion
dynamics and cell movement. Oncogene. 19:5606–5613. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mitra SK, Hanson DA and Schlaepfer DD:
Focal adhesion kinase: in command and control of cell motility. Nat
Rev Mol Cel Biol. 6:56–68. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tomar A and Schlaepfer DD: Focal adhesion
kinase: switching between GAPs and GEFs in the regulation of cell
motility. Curr Opin Cell Biol. 21:676–683. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cance WG, Harris JE, Iacocca MV, et al:
Immunohistochemical analyses of focal adhesion kinase expression in
benign and malignant human breast and colon tissues: correlation
with preinvasive and invasive phenotypes. Clin Cancer Res.
6:2417–2423. 2000.
|
|
30
|
Recher C, Ysebaert L, Beyne-Rauzy O, et
al: Expression of focal adhesion kinase in acute myeloid leukemia
is associated with enhanced blast migration, increased cellularity,
and poor prognosis. Cancer Res. 64:3191–3197. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Schlaepfer DD, Mitra SK and Ilic D:
Control of motile and invasive cell phenotypes by focal adhesion
kinase. Biochim Biophys Acta. 1692:77–102. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Despeaux M, Chicanne G, Rouer E, et al:
Focal adhesion kinase splice variants maintain primitive acute
myeloid leukemia cells through altered Wnt signaling. Stem Cells.
30:1597–1610. 2012. View Article : Google Scholar : PubMed/NCBI
|
